Lion Point Capital’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-78,000	Closed	-$601K	–	30
2024 Q1	$601K	Hold	78,000	–	–	0.34%	19
2023 Q4	$701K	Hold	78,000	–	–	0.35%	16
2023 Q3	$697K	Buy	+78,000	New	+$697K	0.31%	17